Publications
- Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial +12012 | First Faculty of Medicine
- Changes associated with lenalidomide treatment in the gene expression profiles of patients with Del(5q)2012 | First Faculty of Medicine
- Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 72010 | First Faculty of Medicine
- Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy2010 | First Faculty of Medicine
- Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic2010 | First Faculty of Medicine
- MiRNA expression profilig in 5q-syndrome patiens treated with lenalidomidePublication without faculty affiliation
- Gain/amplification of 1q21 is the most powerful genetic prognostic factor for patients treated by autologous stem cell transplantationPublication without faculty affiliation
- Klinický význam rozsahu del(5q) u nemocných s MDS2021 | First Faculty of Medicine, Central Library of Charles University
- Expression of Interferons Lambda 3 and 4 Induces Identical Response in Human Liver Cell Lines Depending Exclusively on Canonical Signaling2021 | First Faculty of Medicine
- Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution2020 | First Faculty of Medicine
Loading network view...